CFB and metabolic disease: For example, when a palatable high-fat diet (HFD) is made available, it is unknown whether Gβγ-SNARE–dependent signals serve to limit or amplify weight gain or contribute to the glucose dysregulation and metabolic inflexibility commonly seen in metabolic disease (22, 23).